Surotomycin versus vancomycin in adults with : primary clinical outcomes from the second pivotal, randomized, double-blind, Phase 3 trialClostridium difficile: primary clinical outcomes from the second pivotal, randomized, double-blind, Phase 3 trial infection: primary clinical outcomes from the second pivotal, randomized, double-blind, Phase 3 trial

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles